Litcius/Paper detail

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

Sebastiano Bruno Solerte, Antonio Di Sabatino, Massimo Galli, Paolo Fiorina

2020Acta Diabetologica210 citationsDOIOpen Access PDF

Topics & Concepts

Dipeptidyl peptidase-4Cytokine stormImmunologyCoronavirusMedicineLungImmune systemPneumoniaCytokineInflammationReceptorVirusRespiratory tractCytotoxic T cellDiabetes mellitusBiologyRespiratory systemCoronavirus disease 2019 (COVID-19)Type 2 diabetesInternal medicineEndocrinologyBiochemistryIn vitroDiseaseInfectious disease (medical specialty)Peptidase Inhibition and AnalysisCOVID-19 Clinical Research StudiesNeuropeptides and Animal Physiology
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19 | Litcius